Dravet syndrome is a rare form of epilepsy that typically begins between 1 and 18 months of age. The first seizure is typically a convulsive seizure, either affecting the full body, which is then called a generalized tonic-clonic seizure, or half of the body, which is called a hemiconvulsion. At onset a patient's neurological exam and MRI are normal, and the patient will have normal or nonspecific EEG findings. Diagnosis can be made through clinical findings: age of onset, type of seizures, length of seizures, seizures that are resistant to therapies, and developmental delays. Around 80% of those diagnosed with Dravet syndrome have the SCN1A mutation which can be confirmed through genetic testing. We met with Carrie, a Dravet syndrome mom to learn about her journey with her daughter, Kaylee, and Dr. Linda Laux, a pediatric epileptologist, to understand more about the diagnosis and management of the disease. We also talked with the CEO of Biocodex, Nicolas Coudurier, and Executive Direc